Elicio Therapeutics, Inc. Contract with Customer, Liability, Noncurrent
Elicio Therapeutics, Inc. (ELTX) had Contract with Customer, Liability, Noncurrent of $0 as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2022-03-30
- 2021-12-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2021-09-30: Contract with Customer, Liability, Noncurrent $23.77M.
- 2021-06-30: Contract with Customer, Liability, Noncurrent $23.71M.
- 2021-03-31: Contract with Customer, Liability, Noncurrent $25.64M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2021-09-30 | $23.77M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $23.71M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $25.64M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $25.86M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |